Prostate Cancer Clinical Trial
Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer
Summary
This clinical trial studies barriers to genetic testing in African American men with prostate cancer and whether tailored, culturally relevant genetic testing education provided by a community-based health coach is beneficial in improving knowledge, attitudes, and awareness of genetic testing. Information gained from this study, may help researchers better understand and learn more about how to increase access to germline genetic testing in underrepresented populations.
Full Description
PRIMARY OBJECTIVE:
I. To assess uptake of genetic testing using tailored education strategies and culturally relevant cancer resources delivered by a community-based health coach.
SECONDARY OBJECTIVE:
I. To assess decisional conflict among African American men receiving tailored education strategies and culturally relevant cancer resources on genetic testing delivered by a community-based health coach.
TERTIARY OBJECTIVE:
I. To assess the germline mutation rate among African American men with prostate cancer.
OUTLINE: Patients are assigned to 1 of 2 cohorts.
COHORT A: Patients complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Patients may also undergo genetic testing.
COHORT B: Patients participate in educational session with health coach over 60 minutes. Patients also complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Patients may undergo genetic testing.
Eligibility Criteria
Inclusion Criteria:
Age >= 18 years old
Speak and read English
Have no known cancer risk genetic mutation
Self-identify as Black or African American
Self-report a diagnosis of regional (lymph node positive), advanced, or metastatic prostate cancer per National Comprehensive Cancer Network (NCCN) guidelines
Exclusion Criteria:
Prior germline genetic test
Age < 18 years old
Unable to read or answer forms
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
San Francisco California, 94143, United States
How clear is this clinincal trial information?